Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8226514 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 7 Pages |
Abstract
This population-based report demonstrates an increasing trend in the use of VB in the adjuvant setting after hysterectomy for treatment of women with FIGO stage I-II EC. VB alone appears to be replacing pelvic EBRT and VB+EBRT therapy in the management of stage I-II EC.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Mehul K. M.D., Michele L. Ph.D., Rouba M.D., Thomas M.D., Adnan R. M.D., Mohamed A. M.D.,